November 18, 2009 (Orlando, Florida) — There was no difference in clinical outcomes between 2.5 mg, 5 mg, and 20 mg daily of carvedilol in Japanese heart-failure patients in the Japanese Chronic Heart ...
A combination of silybin and carvedilol is more effective than either drug alone for treating liver fibrosis, found a new study published in Targetome. Liver fibrosis is a chronic and multifactorial ...
The largest clinical trial ever in chronic heart failure (HF) and the first head-to-head comparison of the effects of 2 beta-blockers on major outcomes has been reported by the investigators to show ...
News Medical on MSN
Repurposed drug combination shows strong promise against liver fibrosis
The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...
Techno-Science.net on MSN
Combination of two known drugs surprises against liver fibrosis
A treatment for a major health problem may already be on the shelves of our pharmacies. Liver fibrosis is a condition that affects hundreds of millions of individuals and progresses silently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results